drugset / Trial / NCT01353690
Autologous Cell Therapy for Ischemic Heart Failure
NaSingle-groupOpen-labelTreatment
Summary
The aim of this clinical study is to investigate the safety and feasibility of Autologous Muscle-derived Cells (AMDC; a preparation of a patient's own cells) as a treatment for patients with advanced heart failure caused by ischemia.
Timeline
- Start
- 2011-02-05
- Primary completion
- 2012-12-12
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous Muscle-derived Cells | Cell therapy | — | — |